Article

Allergan expands Refresh line with new formula for eye allergies

Allergan Inc. has expanded its artificial tears and eye drops product offerings with the addition of ketotifen fumarate ophthalmic solution (Refresh Eye Itch Relief), an over-the-counter eye drop for patients with itchy eyes due to allergies.

Allergan Inc. has expanded its artificial tears and eye drops product offerings with the addition of ketotifen fumarateophthalmic solution (Refresh Eye Itch Relief), an over-the-counter eye drop for patients with itchy eyes due toallergies.

"[This antihistamine eye drop] offers allergy sufferers quick, sustained relief from itchy eyes with the same efficacy as theoriginal prescription formulation of ketotifen fumarate ophthalmic solution," said Joseph Schultz, Allergan's senior vicepresident of sales and marketing, U.S. Eye Care.

The triple-action formula provides a potent antihistamine effect to offer relief in minutes; mast cell stabilization tosustain relief for up to 12 hours; and eosinophil inhibition to prevent late-phase allergic reaction, said the company in aprepared statement. The company has said the product is safe for adults and children ages 3 and older.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.